VivoSeq
Psychiatry

PTSD - Post Traumatic Stress Disorder

1

Pipeline Programs↗

4

Active Trials↗

2

Companies Involved↗

PTSD - Post Traumatic Stress Disorder is an early-stage landscape with 1 program across 2 companies. The most active players are Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Eli Lilly. 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

19/100

Mech. Concentration

100/100

Completion Rate

N/A

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

C

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

1 program

ApprovedEli Lilly logo

Eli Lilly

1 program

Approved

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved1

Suvorexant

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Analysis

Trial Status

4

clinical trials

Not yet recruiting4 · 100%

Clinical Trials

Trial Activity

SPARK-VNS: Facilitating Adaptive Posttraumatic Processing With Non-Invasive Vagus Nerve Stimulation
Not yet recruiting·WWayne State University·Phase 1·NCT06953388·60 enrolled
Intermittent Theta-Burst Stimulation (iTBS) as an add-on to Eye Movement Desensitization and Reprocessing (EMDR) in the Treatment of Post-traumatic Stress Disorder (PTSD): An Open-label Pilot Study
Not yet recruiting·AAarhus University Hospital·Preclinical·NCT07693088·15 enrolled
Suvorexant: Targeting Orexin to Augment Exposure Therapy in Veterans With PTSD and Insomnia
Not yet recruiting·NNorthern California Institute of Research and Education·Approved·NCT07686731·142 enrolled
Preventing Substance Use Among Incarcerated Youth Through Addressing Posttraumatic Stress
Not yet recruiting·UUniversity of California, San Francisco·Preclinical·NCT07682441·28 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)